OnKure Therapeutics Inc. (OKUR) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

OnKure Therapeutics Inc.

NASDAQ: OKUR · Real-Time Price · USD
2.71
-0.09 (-3.21%)
At close: Oct 03, 2025, 3:59 PM
2.76
1.85%
After-hours: Oct 03, 2025, 06:55 PM EDT

OnKure Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a n/a n/a n/a
Cost of Revenue
662K 560K 529K 50K
Gross Profit
-662K -560K -529K -50K
Operating Income
-54.39M -36.93M -29.77M -39.82M
Interest Income
2.01M 1.62M 254K n/a
Pretax Income
-52.67M -35.31M -29.51M -39.77M
Net Income
-52.67M -35.31M -29.51M -39.77M
Selling & General & Admin
10.59M 4.82M 3.9M 11.65M
Research & Development
43.8M 32.12M 25.86M 28.12M
Other Expenses
n/a n/a n/a n/a
Operating Expenses
54.39M 36.93M 29.77M 39.77M
Interest Expense
300K n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
54.39M 36.93M 29.77M 39.82M
Income Tax Expense
n/a n/a n/a n/a
Shares Outstanding (Basic)
13.34M 13.34M 13.34M 1.81M
Shares Outstanding (Diluted)
13.34M 13.34M 13.34M 1.81M
EPS (Basic)
-3.95 -2.65 -2.21 -21.92
EPS (Diluted)
-3.95 -2.65 -2.21 -21.92
EBITDA
-51.71M -34.75M -29.38M -39.72M
EBIT
-52.37M -35.31M -29.77M -39.77M
Depreciation & Amortization
662K 560K 387K 50K